InfuSystem Holdings (INFU) Profit After Tax Growth (3y) (2013 - 2026)
InfuSystem Holdings (INFU) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 49.66% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -7.65% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 9.79% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 97.37% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 15.46% |
| 10 | InfuSystem Holdings | 242.86 Mn | 241.90 Mn | 21.41 Mn | 75.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75.16% |
| Mar 31, 2026 | 57.29% |
| Dec 31, 2025 | 356.75% |
| Sep 30, 2025 | 34.28% |
| Jun 30, 2025 | 388.37% |
| Mar 31, 2025 | -41.56% |
| Dec 31, 2024 | 48.28% |
| Sep 30, 2024 | 71.10% |
| Jun 30, 2024 | -4.38% |
| Mar 31, 2024 | -49.89% |
| Dec 31, 2023 | -26.92% |
| Sep 30, 2023 | -38.35% |
| Jun 30, 2023 | -47.27% |
| Mar 31, 2023 | -9.11% |
| Dec 31, 2022 | -26.54% |
| Sep 30, 2022 | -7.37% |
| Jun 30, 2022 | -61.94% |
| Mar 31, 2022 | 32.62% |
| Dec 31, 2021 | -40.64% |
| Sep 30, 2021 | 4.79% |